Your browser is no longer supported. Please, upgrade your browser.
EYES Second Sight Medical Products, Inc. monthly Stock Chart
EYES [NASD]
Second Sight Medical Products, Inc.
Index- P/E- EPS (ttm)-0.47 Insider Own0.10% Shs Outstand120.13M Perf Week10.47%
Market Cap97.00M Forward P/E- EPS next Y-0.26 Insider Trans-21.13% Shs Float45.82M Perf Month13.86%
Income-35.00M PEG- EPS next Q-0.06 Inst Own6.50% Short Float10.29% Perf Quarter1.57%
Sales7.00M P/S13.86 EPS this Y-0.40% Inst Trans6.94% Short Ratio17.03 Perf Half Y6.25%
Book/sh0.30 P/B2.69 EPS next Y13.30% ROA-188.70% Target Price2.50 Perf Year-54.12%
Cash/sh0.26 P/C3.06 EPS next 5Y- ROE-333.30% 52W Range0.64 - 1.98 Perf YTD-8.81%
Dividend- P/FCF- EPS past 5Y4.40% ROI- 52W High-59.22% Beta2.21
Dividend %- Quick Ratio4.50 Sales past 5Y34.50% Gross Margin29.70% 52W Low27.15% ATR0.06
Employees123 Current Ratio4.70 Sales Q/Q10.00% Oper. Margin- RSI (14)56.17 Volatility6.37% 7.81%
OptionableYes Debt/Eq0.00 EPS Q/Q39.20% Profit Margin- Rel Volume2.02 Prev Close0.79
ShortableYes LT Debt/Eq0.00 EarningsMay 15 AMC Payout- Avg Volume276.77K Price0.81
Recom- SMA2012.52% SMA50-4.83% SMA200-24.52% Volume557,779 Change1.80%
Jul-06-15Initiated H.C. Wainwright Buy $21
Jun-25-19 04:05PM  Researchers Present Latest Positive Results of Second Sights Orion Visual Cortical Prosthesis Feasibility Study Business Wire
May-30-19 02:01PM  Edited Transcript of EYES earnings conference call or presentation 15-May-19 8:30pm GMT Thomson Reuters StreetEvents +7.75%
May-16-19 05:00PM  Second Sight to Present at 20th Annual B. Riley FBR Investor Conference Business Wire -8.42%
May-15-19 05:25PM  Second Sight Medical Products (EYES) Reports Q1 Loss, Misses Revenue Estimates Zacks -7.48%
04:15PM  Second Sight Medical Products: 1Q Earnings Snapshot Associated Press
04:05PM  Second Sight Reports First Quarter 2019 Financial Results Business Wire
04:01PM  Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System Business Wire
May-08-19 08:00AM  Second Sight to Discuss First Quarter 2019 Financial Results on May 15, 2019 Conference Call Business Wire
May-02-19 10:32AM  Second Sight Medical Products (EYES) May Report Negative Earnings: Know the Trend Ahead of Q1 Release Zacks
Apr-17-19 09:13AM  Imagine Owning Second Sight Medical Products (NASDAQ:EYES) And Trying To Stomach The 80% Share Price Drop Simply Wall St. -5.66%
Apr-11-19 08:00AM  Second Sight Medical Products, Inc. Presents Positive Interim Results at the Fifth Annual BRAIN Initiative® Investigators Meeting Business Wire -9.21%
Apr-04-19 10:49AM  Zacks.com featured highlights include: VALE, Second Sight, Carbonite, Arconic and vTv Zacks
Apr-03-19 02:48PM  Edited Transcript of EYES earnings conference call or presentation 13-Mar-19 8:30pm GMT Thomson Reuters StreetEvents
07:57AM  Get Over Bargain Hunting: Tap 5 Stocks With Rising P/E Zacks
Mar-19-19 12:26PM  Zacks.com featured highlights include: Catabasis, Ligand, Key, Carbonite and Second Sight Zacks
Mar-18-19 09:02AM  Rising P/E an Overlooked Criterion: 5 Top Stocks Zacks
Mar-13-19 04:34PM  Second Sight Medical Products: 4Q Earnings Snapshot Associated Press
04:05PM  Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results Business Wire
Mar-12-19 08:46AM  Have Insiders Been Buying Second Sight Medical Products, Inc. (NASDAQ:EYES) Shares This Year? Simply Wall St. +7.75%
Mar-06-19 08:00AM  Second Sight to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019 Conference Call Business Wire
Feb-21-19 06:06PM  Second Sight Medical Products, Inc. Announces Completion of Rights Offering Business Wire +5.33%
Jan-22-19 07:35AM  Recent Analysis Shows Abercrombie & Fitch, DaVita, W.W. Grainger, Ingredion, FirstEnergy, and Second Sight Medical Products Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Jan-07-19 08:05AM  Second Sight Medical Products, Inc. Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants (EYESW) Expiration Date GlobeNewswire
08:00AM  Second Sight Reports Fourth Quarter 2018 Business Update GlobeNewswire
Dec-20-18 08:00AM  Second Sight to Present at Digital Medicine and Medtech Showcase 2019 GlobeNewswire
Dec-14-18 08:00AM  Second Sight Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors GlobeNewswire +6.31%
Dec-04-18 06:18AM  Second Sight Medical Products Sees Hammer Chart Pattern: Time to Buy? Zacks -5.09%
Dec-03-18 08:17PM  Edited Transcript of EYES earnings conference call or presentation 7-Nov-18 9:30pm GMT Thomson Reuters StreetEvents
Nov-27-18 04:30PM  Second Sight to Present at the 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th GlobeNewswire
Nov-12-18 08:15AM  Research Report Identifies Prudential Financial, Second Sight Medical Products, Acushnet, Repligen, Scorpio Tankers, and Aethlon Medical with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire -5.84%
Nov-07-18 07:10PM  Second Sight Medical Products (EYES) Reports Q3 Loss, Lags Revenue Estimates Zacks
06:06PM  Second Sight Medical Products: 3Q Earnings Snapshot Associated Press
04:01PM  Second Sight Reports Third Quarter 2018 Financial Results GlobeNewswire
Nov-06-18 04:01PM  Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System GlobeNewswire
Oct-30-18 08:00AM  Second Sight to Discuss Third Quarter 2018 Financial Results on November 7, 2018 Conference Call Business Wire
Oct-22-18 09:00AM  Second Sight Completes $4 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors Business Wire
Oct-18-18 08:30AM  New Research Coverage Highlights QuinStreet, Senseonics, Ring Energy, Blue Apron, Second Sight Medical Products, and Real Goods Solar Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Sep-18-18 08:00AM  Second Sight Receives $1.6 Million Grant from National Institutes of Health to Support Orion Clinical Development Business Wire
Sep-04-18 08:00AM  Second Sight Appoints Pat Ryan Chief Operating Officer Business Wire
Aug-27-18 07:40AM  Analysis: Positioning to Benefit within C&J Energy Services, LivePerson, Kadmon, Cara Therapeutics, CorMedix, and Second Sight Medical Products Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Aug-22-18 08:00AM  Second Sight to Present at Investor Conferences in September Business Wire
Aug-16-18 08:26AM  Second Sight Medical Products (EYES): Moving Average Crossover Alert Zacks
08:00AM  Second Sight Completes $5.0 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors Business Wire
03:35AM  Edited Transcript of EYES earnings conference call or presentation 7-Aug-18 8:30pm GMT Thomson Reuters StreetEvents
Aug-07-18 04:53PM  Second Sight Medical Products: 2Q Earnings Snapshot Associated Press
04:05PM  Second Sight Reports Second Quarter 2018 Financial Results Business Wire
02:30PM  Second Sight Medical Products, Inc. to Host Earnings Call ACCESSWIRE
Jul-31-18 08:00AM  Second Sight to Discuss Second Quarter 2018 Financial Results on August 7, 2018 Conference Call Business Wire
Jun-27-18 10:53AM  Second Sight Medical Products Incs (NASDAQ:EYES) Shift From Loss To Profit Simply Wall St.
Jun-21-18 08:25AM  Analysis: Positioning to Benefit within Second Sight Medical Products, ICF International, Morningstar, Spark Therapeutics, Natera, and Kadmon Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
May-23-18 07:15AM  Complimentary Technical Snapshots on Prestige Brands and Three More Medical Equipment Stocks ACCESSWIRE
May-14-18 08:00AM  Second Sight Medical Products, Inc. to Present at the 19th Annual B. Riley FBR Investor Conference Business Wire
May-10-18 04:48PM  Second Sight Medical Products: 1Q Earnings Snapshot Associated Press -5.39%
04:01PM  Second Sight Reports First Quarter 2018 Financial Results Business Wire
May-07-18 08:00AM  Second Sight Completes $10 Million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors Business Wire -7.27%
May-03-18 05:00PM  Second Sight to Discuss First Quarter 2018 Financial Results on May 10, 2018 Conference Call Business Wire
May-01-18 08:10AM  Research Report Identifies Flexsteel Industries, Second Sight Medical Products, XG Technology, CRA International, Inc, Neos Therapeutics, and Tech Data with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Apr-09-18 04:30PM  Second Sight Announces Dr. Robert Greenbergs Resignation from Board of Directors and as an Officer of the Company Business Wire
Mar-22-18 08:00AM  Second Sight Appoints John T. Blake Chief Financial Officer Business Wire
Mar-19-18 07:30AM  Research Report Identifies Anthera Pharmaceuticals, Hancock Holding, MKS Instruments, Second Sight Medical Products, Eclipse Resources, and Aircastle with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Mar-16-18 08:00AM  Second Sight Appoints Gregg Williams as Chairman of the Board of Directors Business Wire
Mar-08-18 04:30PM  Second Sight Medical Products, Inc. to Present at the B. Riley & Co. China Healthcare Investment Partnering Symposium Business Wire -6.49%
Mar-07-18 05:47PM  Second Sight Medical Products posts 4Q loss Associated Press
04:05PM  Second Sight Reports Fourth Quarter and Full Year 2017 Financial Results Business Wire
12:30PM  Second Sight Medical Products, Inc. to Host Earnings Call ACCESSWIRE
Mar-06-18 08:00AM  Second Sight Announces Latest Expansion of Medicare Coverage for Argus II Retinal Prosthesis System Business Wire
Mar-05-18 08:00AM  Second Sight Medical Products, Inc. to Present at the Inaugural LD Micro Virtual Investor Conference on March 7, 2018 Business Wire +9.04%
Feb-28-18 08:00AM  Second Sight to Discuss Fourth Quarter and Year-End 2017 Financial Results on March 7, 2018 Conference Call Business Wire
Feb-16-18 08:00AM  Second Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis System Business Wire
Feb-07-18 08:00AM  Second Sight Medical, Investors Open Their Eyes Making These Shares Soar, Recent Developments ACCESSWIRE
Feb-06-18 09:21AM  Second Sight Medical Products Inc Execution Is Firing on All Cylinders Following Standout 4Q:17 Implants SmarterAnalyst -13.42%
08:55AM  Second Sight (EYES) Catches Eye: Stock Jumps 12.7% Zacks
Feb-05-18 08:00AM  Second Sight Announces Record Number of Argus II Retinal Prosthesis Systems Implants and Completes First-in-Human Orion Cortical Implant Business Wire +12.68%
Feb-01-18 11:02AM  High Growth Stocks To Invest In Simply Wall St.
Jan-09-18 08:30AM  Investor Expectations to Drive Momentum within Cutera, Matrix Service, PRA Group, Materion, Second Sight Medical Products, and Syndax Pharmaceuticals Discovering Underlying Factors of Influence GlobeNewswire
Dec-31-17 11:02AM  January Growth Opportunities Athenex And More Simply Wall St.
Dec-12-17 01:11PM  ETFs with exposure to Second Sight Medical Products, Inc. : December 12, 2017 Capital Cube +17.50%
Dec-07-17 08:48AM  Second Sight Medical (EYES) in Focus: Stock Moves 12.1% Higher Zacks
Dec-05-17 09:00AM  Second Sight Announces Market Entry into Iran with First Two Implants of Argus II Retinal Prosthesis System Business Wire
Nov-30-17 01:48PM  ETFs with exposure to Second Sight Medical Products, Inc. : November 30, 2017 Capital Cube -6.82%
Nov-20-17 12:25PM  ETFs with exposure to Second Sight Medical Products, Inc. : November 20, 2017 Capital Cube
Nov-10-17 12:22PM  ETFs with exposure to Second Sight Medical Products, Inc. : November 10, 2017 Capital Cube
08:00AM  Ontario Health Technology Advisory Committee Recommends Public Funding for Second Sights Argus II Retinal Prosthesis System Business Wire
Nov-09-17 09:03AM  Second Sight Medical Products, Inc. :EYES-US: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017 Capital Cube
Nov-08-17 08:00AM  Second Sight Receives FDA Expedited Access Pathway Designation for the Orion Cortical Visual Prosthesis System Business Wire
Nov-02-17 05:19PM  Second Sight Medical Products posts 3Q loss Associated Press +7.41%
04:00PM  Second Sight Reports Third Quarter 2017 Financial Results Business Wire
08:05AM  Second Sight Receives Full FDA Approval to Begin First Orion Human Clinical Study Business Wire
08:00AM  Second Sight Announces Final Medicare Hospital Outpatient Payment Rate for 2018 for the Argus II Retinal Prosthesis System Business Wire
Oct-26-17 08:00AM  Second Sight to Discuss Third Quarter 2017 Financial Results on November 2, 2017 Conference Call Business Wire
Oct-24-17 09:38AM  ETFs with exposure to Second Sight Medical Products, Inc. : October 24, 2017 Capital Cube
Oct-19-17 07:00AM  Second Sight Announces Appointments of Frank Vandeputte as Vice President and General Manager, EMEA and Asia Pacific; Gregoire Cosendai as Vice President, Clinical Affairs Business Wire
Oct-17-17 10:00AM  Second Sight Medical Products Inc (EYES) to Initiate Study of Argus II in Better-Sighted Retinitis Pigmentosa Patients; Shares Rose 5% SmarterAnalyst
07:00AM  Second Sight Receives Approval from Bundesinstitut für Arzneimittel und Medizinprodukte in Germany to Begin Study to Implant and Evaluate Argus II in Better-Sighted Retinitis Pigmentosa Patients Business Wire
Oct-13-17 10:46AM  ETFs with exposure to Second Sight Medical Products, Inc. : October 13, 2017 Capital Cube
Oct-02-17 10:50AM  ETFs with exposure to Second Sight Medical Products, Inc. : October 2, 2017 Capital Cube
Sep-29-17 09:03AM  Second Sight Medical Products, Inc. :EYES-US: Earnings Analysis: Q2, 2017 By the Numbers : September 29, 2017 Capital Cube
Sep-05-17 08:00AM  Second Sight to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York on September 12th Business Wire
Aug-28-17 08:00AM  Second Sight Receives Conditional FDA Approval to Begin First Orion Human Clinical Study Business Wire +8.00%
Aug-01-17 09:57PM  Second Sight Medical Products posts 2Q loss Associated Press
Second Sight Medical Products, Inc. develops, manufactures, and markets implantable visual prosthetics that are intended to deliver artificial vision to blind individuals. It develops technologies to treat the population of sight-impaired individuals. The company offers the Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, which is intended to provide useful artificial vision to individuals who are blind due to various causes, including glaucoma, diabetic retinopathy, optic nerve injury or disease, and eye injury. It also offers Argus II Retinal Prosthesis System for treating retinitis pigmentosa. The company was founded in 1998 and is headquartered in Sylmar, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Randolph Edward DavidVice President ManufacturingJun 04Sale0.7123,58616,64922Jun 04 07:26 PM
McGuire Jonathan WillChief Executive OfficerMay 21Sale0.853,8673,287128,088May 22 05:58 PM
McGuire Jonathan WillChief Executive OfficerMay 20Option Exercise0.0011,8750131,955May 22 05:58 PM
McGuire Jonathan WillChief Executive OfficerFeb 20Sale0.734,7243,436113,126Feb 21 07:45 PM
McGuire Jonathan WillChief Executive OfficerFeb 19Option Exercise0.0011,8750117,850Feb 21 07:45 PM
Williams GreggDirectorDec 12Buy0.923,275,1002,999,99236,255,772Dec 14 08:27 AM
Randolph Edward DavidVice President - ManufacturingDec 03Sale1.033,7333,84122Dec 04 08:31 AM
OKLAND STEPHEN DChief Commercial OfficerDec 03Sale1.037,7647,98923,641Dec 04 08:30 AM
McGuire Jonathan WillChief Executive OfficerNov 21Sale1.163,9204,547103,753Nov 21 08:44 PM
McGuire Jonathan WillChief Executive OfficerNov 20Option Exercise0.0011,8750107,673Nov 21 08:44 PM
Williams GreggDirectorOct 18Buy1.622,467,7673,997,78332,980,672Oct 22 07:49 PM
Williams GreggDirectorOct 16Buy1.689,98816,82030,512,945Oct 16 06:47 PM
Williams GreggDirectorOct 15Buy1.637,64512,43830,502,957Oct 16 06:47 PM
Williams GreggDirectorOct 12Buy1.627,69412,44930,495,312Oct 12 09:33 PM
Williams GreggDirectorOct 11Buy1.6011,70918,74630,487,618Oct 12 09:33 PM
Williams GreggDirectorOct 10Buy1.6015,87525,43230,475,909Oct 10 08:05 PM
Williams GreggDirectorOct 09Buy1.6410,45817,18230,460,034Oct 10 08:05 PM
Williams GreggDirectorOct 05Buy1.7215,87527,30530,449,576Oct 09 09:30 AM
Williams GreggDirectorOct 04Buy1.7910,89419,44630,433,701Oct 09 09:30 AM
Williams GreggDirectorOct 03Buy1.768,20014,39130,422,807Oct 04 06:09 PM
Williams GreggDirectorOct 02Buy1.8115,87528,75030,414,607Oct 04 06:09 PM
Williams GreggDirectorOct 01Buy1.8615,87529,54330,398,732Oct 01 08:56 PM
Williams GreggDirectorSep 28Buy1.909,22317,54230,382,857Oct 01 08:56 PM
Williams GreggDirectorSep 27Buy1.9315,87530,70230,373,634Sep 27 08:17 PM
Williams GreggDirectorSep 26Buy1.9610,87821,28830,357,759Sep 27 08:17 PM
Williams GreggDirectorSep 25Buy1.8915,87529,92430,346,881Sep 25 06:52 PM
Williams GreggDirectorSep 24Buy1.8615,52028,88330,331,006Sep 25 06:52 PM
Williams GreggDirectorSep 21Buy1.8015,87528,49630,315,486Sep 21 09:28 PM
Williams GreggDirectorSep 20Buy1.8215,87528,90830,299,611Sep 21 09:28 PM
Williams GreggDirectorSep 19Buy1.7613,74124,17030,283,736Sep 19 08:24 PM
Williams GreggDirectorSep 18Buy1.8715,87529,73430,269,995Sep 19 08:24 PM
Williams GreggDirectorSep 17Buy1.7915,87528,41630,254,120Sep 17 08:25 PM
Williams GreggDirectorSep 14Buy1.6910,20017,21830,238,245Sep 17 08:25 PM
Williams GreggDirectorSep 13Buy1.6715,87526,54330,228,045Sep 13 07:26 PM
Williams GreggDirectorSep 12Buy1.6215,87525,76530,212,170Sep 13 07:26 PM
Williams GreggDirectorSep 11Buy1.6815,87526,62230,196,295Sep 12 01:23 PM
Williams GreggDirectorSep 10Buy1.6910,60817,91730,180,420Sep 12 01:23 PM
Williams GreggDirectorSep 07Buy1.7315,87527,44830,169,812Sep 10 06:03 AM
Williams GreggDirectorSep 06Buy1.7615,87527,92430,153,937Sep 10 06:03 AM
Williams GreggDirectorSep 05Buy1.7014,95325,40530,138,062Sep 05 07:57 PM
Williams GreggDirectorSep 04Buy1.6815,87526,63830,123,109Sep 05 07:57 PM
Williams GreggDirectorAug 31Buy1.7315,87527,48030,107,234Aug 31 08:32 PM
Williams GreggDirectorAug 30Buy1.7115,87527,19430,091,359Aug 31 08:32 PM
Williams GreggDirectorAug 29Buy1.6115,72025,37230,075,484Aug 29 09:36 PM
Williams GreggDirectorAug 28Buy1.5914,14022,42630,059,764Aug 29 09:36 PM
Williams GreggDirectorAug 27Buy1.5710,62316,72130,045,624Aug 27 09:43 PM
Williams GreggDirectorAug 24Buy1.5912,70020,24430,035,001Aug 27 09:43 PM
Williams GreggDirectorAug 23Buy1.625,9839,70430,022,301Aug 23 07:51 PM
Williams GreggDirectorAug 22Buy1.6311,06918,08730,016,318Aug 23 07:51 PM
Williams GreggDirectorAug 21Buy1.6315,87525,84530,005,249Aug 21 07:24 PM
McGuire Jonathan WillChief Executive OfficerAug 20Option Exercise0.0011,8750119,575Aug 22 03:24 PM
Williams GreggDirectorAug 20Buy1.574,1106,46929,989,374Aug 21 07:24 PM
Williams GreggDirectorAug 17Buy1.567,80012,13729,985,264Aug 17 08:28 PM
Williams GreggDirectorAug 16Buy1.5610,26316,01029,977,464Aug 17 08:28 PM
Williams GreggDirectorAug 15Buy1.5315,87524,28929,967,201Aug 16 05:43 PM
Williams GreggDirectorAug 14Buy1.553,231,4875,008,86729,951,326Aug 16 05:43 PM
Williams GreggDirectorAug 13Buy1.607,00011,16526,719,839Aug 13 09:25 PM
Williams GreggDirectorAug 10Buy1.5515,87524,62226,712,839Aug 13 09:25 PM
Williams GreggDirectorAug 09Buy1.546,63410,24326,696,964Aug 09 06:23 PM
Williams GreggDirectorAug 08Buy1.5815,87525,11426,690,330Aug 09 06:23 PM
Williams GreggDirectorAug 07Buy1.677,96013,32526,674,455Aug 07 06:31 PM
Williams GreggDirectorAug 06Buy1.668,18813,56826,666,495Aug 07 06:31 PM
Williams GreggDirectorJul 27Buy1.6015,87525,43226,658,307Jul 30 08:18 PM
Williams GreggDirectorJul 26Buy1.657,87413,01626,642,432Jul 30 08:18 PM
Williams GreggDirectorJul 25Buy1.6010,40216,68526,635,638Jul 25 08:41 PM
Williams GreggDirectorJul 24Buy1.6215,87525,71826,625,236Jul 25 08:41 PM
Williams GreggDirectorJul 23Buy1.6715,87526,44826,609,361Jul 24 06:58 PM
Williams GreggDirectorJul 20Buy1.678,60114,38926,593,486Jul 24 06:58 PM
Williams GreggDirectorJul 19Buy1.696,88511,66326,584,885Jul 19 07:43 PM
Williams GreggDirectorJul 18Buy1.7215,87527,35326,578,000Jul 19 07:43 PM
Williams GreggDirectorJul 17Buy1.8015,87528,51226,562,125Jul 18 09:50 PM
Williams GreggDirectorJul 16Buy1.779,70017,12126,546,250Jul 18 09:50 PM